Erik has 13 years’ experience as an IP and regulatory lawyer. After completing a stage at the European Commission, he spent two years in the EU department at Liederkerke Siméon Wessing Houthoff and subsequently worked as core member of the industry group "Healthcare, Life Sciences and Chemicals" at the Amsterdam and Brussels offices of Clifford Chance from 1999 until 2007. He was responsible for Greenberg Traurig’s European life sciences practice from 2007 to 2011 and is a founding partner of the EU life sciences firm, Axon.
His practice comprises advice to and litigation for clients from the pharmaceutical, medical device and biotechnology industry in legal, regulatory, intellectual property and anti-trust matters.
Erik is a respected author of a number of publications on legal and regulatory subjects relating to pharmaceuticals and medical devices as well as editor of two Dutch legal journals in the field of pharmaceutical law and medical technology law. He has also authored the medical device law section of the Dutch language loose leaf commentary on pharmaceutical and medical technology law. He is a frequent speaker at national and international conferences, including DIA and RAPS.